Cell Culture Media Market Analysis & Opportunity Outlook 2023-2035

Global Cell Culture Media Market Size, Forecast, and Trend Highlights Over 2023 - 2035

The global cell culture media market size is estimated to reach ~USD 54 Billion by the end of 2035 by growing at a CAGR of ~19% over the forecast period, i.e., 2023 – 2035. In addition to this, in the year 2022, the market size of the cell culture media market was ~USD 7 Billion. The growth of the market can be attributed to the increasing advancements in the field of molecular biology along with the rising advances in biological science accelerating the bio revolution globally. For instance, researchers worldwide estimate that biological applications alone are expected to exhibit a direct positive economic impact of almost USD 4 trillion a year globally over the next 10 to 20 years.

The cell culture media is vital to the culture environment. It provides those components that essentially support cell growth and function. Further, as the environmental conditions in cell culture, including osmotic pressure and pH, can be regulated with the formulation of media, a variety of cell culture media formulations have been developed to support a wide range of cell types and experimental applications. Hence, with the growing global burden of diseases, as well as the rising focus and expenditure on research and development proficiencies concerning cell-based research, cell culture media is predicted to present the potential for market expansion over the projected period. For instance, according to the World Health Organization, ischemic heart disease alone was responsible for the largest increase in deaths worldwide with over 2 million in the last two decades (2000-2019).

Global Cell Culture Media Market: Growth Drivers and Challenges

Growth Drivers

Increasing Advancements in Human Genetics and Genome Research – Rising attempts to understand the structure and function of genetic sequences and of downstream biological products that determine the genetic bases of many diseases are leading toward the surging exploration in the field of genomics. The potential of the human genetics and the genomics industry is anticipated by the direct economy generated by this industry in America in 2020 which exceeded USD 108 billion. Hence, the growing advancements in the field of genetic engineering as well as the increasing use of cell medium for tissue preservation and modification of cells are expected to boost the cell culture media market over the forecast period.
Rising Research & Development (R&D) Spending in the Biopharmaceutical Sector – The surge in the demand for vaccines, blood, and blood components, allergenic to treat allergies, body cells and tissues, living cells used in cell therapies, gene therapies, and recombinant therapeutic proteins is responsible for the increasing R&D by the biopharma companies. For instance, as per findings, the biopharmaceutical industry in the U.S. invested around USD 102 billion into R&D in 2018. This surge in investments is also anticipated to propel the market expansion of cell culture media in the upcoming years as many of these products are designed to support the growth and maintenance of a variety of human cells and cell lines which enables various drug development.
Growing Number of Regenerative Medicine Companies - the rising prevalence of chronic diseases as well as the increasing number of organ transplantation cases, and advancements in new product launches are all attributed to the growth of the regenerative medicine facilities. As of 2023, there are over 1,457 companies of regenerative medicine worldwide. This robust expansion is anticipated to propel market growth.
Increasing Investment in Healthcare Sector with Rising Healthcare Expenditure - The elevated burden of chronic diseases along with the surge in the number of surgical procedures is leading to rising investment in the healthcare sector across the globe. According to the data provided by the sources, when it comes to health care the United States is the highest-spending country worldwide. The overall health expenditure in the U.S. rose beyond USD 4 trillion in 2020. Moreover, expenditure as a percentage of GDP is anticipated to rise by about 20% by the year 2028.

Challenges

Challenges related to reproducibility, contamination, viability, and the transition to automation – prevail despite the adoption of different approaches and techniques and this is anticipated to hamper the market growth over the forecast period. The market is facing difficulty to grow viable cells in the desired quantity to obtain reproducible results, owing to which the growth of the market is restricted. Moreover, as isolated cells are highly vulnerable to contamination, their preventive handling and processing is a major threat.
Stringent regulatory frameworks involved in process manufacturing
Dearth of skilled professional

Global Cell Culture Media Market Segmentation

The global cell culture media market is segmented and analyzed for demand and supply by type into liquid media, semi-solid media, and solid media. Out of the three types of cell culture media, the liquid segment is estimated to gain the largest market share of about ~38% in the year 2035. The growth of the segment can be attributed to the rising investment in the pharmaceutical sector as well as the increasing collaborations amongst major players as well as R&D in the field of life sciences for novel drug development and therapeutic research. For instance, recently in March 2023, Nucleus Biologics, The Cell Performance Company, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, in a joint effort to accelerate high-quality therapies to market, announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), leading contract development and manufacturing organization (CDMO). The mission of CDMO is to save lives by accelerating the development and manufacture of advanced therapies.

The global cell culture media market is also segmented and analyzed for demand and supply by end-user into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, and others. Amongst these segments, the pharmaceutical & biotechnology segment is expected to garner a significant share of around ~46% in the year 2035. The rising share of sales of biotechnology drugs worldwide which amounted to over USD 400 billion in 2022 is anticipated to boost the segment growth. On the other hand, the research & academics segment is projected to witness a massive CAGR during the forecast period, owing to the increasing research and development proficiencies in the direction of cell culture media along with the rising advancement in stem cell therapies. This, as a result, is also anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global cell culture media market includes the following segments:

By Type	Liquid Media Semi-Solid Media Solid Media
By Product	Serum-Free Media Classical Media Stem Cell Culture Media Specialty Media Others
By Application	Biopharmaceutical Production Vaccines Production Monoclonal Antibodies Other Therapeutic Proteins Diagnostics Drug Screening & Development Tissue Engineering & Regenerative Medicine Cell & Gene Therapy Other Tissue Engineering & Regenerative Medicine Applications Others
By End User	Hospitals & Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Research & Academic Institutes Others

Global Cell Culture Media Market Regional Synopsis

The market share of cell culture media in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed majorly to the growing investment in the biopharmaceutical sector as well as growing advancements in the field of gene therapy, tissue engineering, production of vaccines, antibiotics, and artificial hormones. As per findings, federal research funding, in the field of human genetics and genomics research reached about USD 3.3 billion in 2019. Moreover, the rising number of organ transplants as well as the increasing popularity of processes such as in vitro fertilization, and cryo-preservation is also anticipated to boost the regional market growth.

The Asia Pacific cell culture media market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the rising investment in the field of biotechnology and the growing investigations of basic cell biology together with the rising approvals for cell culture-based vaccines and therapeutics. Moreover, the rising prevalence of immune diseases along with increasing incidence owing to diseases such as cancer that necessitates the replication of disease mechanisms, besides investigating the toxicity of novel drug compounds is also anticipated to boost the market growth in the region.

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market in the region can primarily be attributed to the growing geriatric population as well as the surge in demand for personalized medicine, along with the expanding R&D activities for various chronic diseases. Additionally, the presence, as well as the expansion of some major players in the region, is further expected to boost regional market growth.

Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Global Cell Culture Media Market

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Corning Incorporated
Sigma-Aldrich Co.
Merck KGaA
Becton, Dickinson, and Company
Cell Culture Technologies
PromoCell GmbH,
VWR International, LLC
Bio-Rad Laboratories, Inc.
Fujifilm Holdings Corporation
Sartorius AG

In The News

Thermo Fisher Scientific Inc., announced the expansion of cell culture media manufacturing site in Grand Island, New York, to meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics. It’s a dry powder media manufacturing facility that provides the redundant capacity to support a global supply of media needed for the development and commercial manufacturing of vaccines and biological therapies.
Merck KGaA, a leading science and technology company, announced the completion of a USD 2.8 million expansion to its Irvine biopharmaceutical production facility which is Merck’s only location where both liquid and powder cell culture media are manufactured.

Global Economic Impact

Request Insights

Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the cell culture media market?

Ans: The increasing research in the field of molecular biology as well as the growing R&D spending by biopharma companies along with rising development in the genome industry are the major factors driving the market growth.

2) What would be the CAGR of cell culture media market over the forecast period?

Ans: The market size of cell culture media is anticipated to attain a CAGR of ~19% over the forecast period, i.e., 2023 – 2035.

3) What are the challenges affecting the cell culture media market growth?

Ans: Stringent regulatory frameworks regarding process manufacturing as well as a lack of skilled professionals are estimated to be the growth hindering factors for the market expansion.

4) Which region will provide more business opportunities for growth of cell culture media market in future?

Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

5) Who are the major players dominating the cell culture media market?

Ans: The major players in the market are Thermo Fisher Scientific Inc., Corning Incorporated, Sigma-Aldrich Co., Merck KGaA, Becton, Dickinson, and Company, Cell Culture Technologies, PromoCell GmbH, VWR International, LLC, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the cell culture media market?

Ans: The market is segmented by type, product, application, end-user, and by region.

8) Which segment captures the largest market size in the type segment in the cell culture media market?

Ans: The liquid media segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Base Year	2022
Forecast Year	2023-2035
CAGR	~19%
Base Year Market Size (2022)	~ USD 7 Billion
Forecast Year Market Size (2035)	~ USD 54 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)